The Recombinant Approach To Produce Semaglutide Api
The recombinant production of semaglutide is a "semi-recombinant" process that combines genetic engineering fermentation and chemical modification, and the core is to express intermediate peptides through microorganisms, and then enzymatic digestion, chemical modification and purification to obtain the final product. Here are the key process steps and technical points: